November 21, 2016
Japanese generic major Sawai Pharmaceutical said on November 18 that the Intellectual Property High Court ruled in favor of the company by upholding the Japan Patent Office’s (JPO) decision to invalidate the usage patent for Eli Lilly’s osteoporosis med Evista...read more